MYH3
Myosin-3
Also known as: HEMHC, MYH3_HUMAN, MYHC-EMB, MYHSE1, SMHCE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11055
- Gene
- MYH3
- Ensembl
- ENSG00000109063
- Chromosome
- 17
- Canonical length
- 1940 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1940 residues, UniProt reviewed canonical sequence.
>P11055|MYH3
1 MSSDTEMEVF GIAAPFLRKS EKERIEAQNQ PFDAKTYCFV VDSKEEYAKG KIKSSQDGKV
61 TVETEDNRTL VVKPEDVYAM NPPKFDRIED MAMLTHLNEP AVLYNLKDRY TSWMIYTYSG
121 LFCVTVNPYK WLPVYNPEVV EGYRGKKRQE APPHIFSISD NAYQFMLTDR ENQSILITGE
181 SGAGKTVNTK RVIQYFATIA ATGDLAKKKD SKMKGTLEDQ IISANPLLEA FGNAKTVRND
241 NSSRFGKFIR IHFGTTGKLA SADIETYLLE KSRVTFQLKA ERSYHIFYQI LSNKKPELIE
301 LLLITTNPYD YPFISQGEIL VASIDDAEEL LATDSAIDIL GFTPEEKSGL YKLTGAVMHY
361 GNMKFKQKQR EEQAEPDGTE VADKTAYLMG LNSSDLLKAL CFPRVKVGNE YVTKGQTVDQ
421 VHHAVNALSK SVYEKLFLWM VTRINQQLDT KLPRQHFIGV LDIAGFEIFE YNSLEQLCIN
481 FTNEKLQQFF NHHMFVLEQE EYKKEGIEWT FIDFGMDLAA CIELIEKPMG IFSILEEECM
541 FPKATDTSFK NKLYDQHLGK SNNFQKPKVV KGRAEAHFSL IHYAGTVDYS VSGWLEKNKD
601 PLNETVVGLY QKSSNRLLAH LYATFATADA DSGKKKVAKK KGSSFQTVSA LFRENLNKLM
661 SNLRTTHPHF VRCIIPNETK TPGAMEHSLV LHQLRCNGVL EGIRICRKGF PNRILYGDFK
721 QRYRVLNASA IPEGQFIDSK KACEKLLASI DIDHTQYKFG HTKVFFKAGL LGTLEEMRDD
781 RLAKLITRTQ AVCRGFLMRV EFQKMVQRRE SIFCIQYNIR SFMNVKHWPW MKLFFKIKPL
841 LKSAETEKEM ATMKEEFQKT KDELAKSEAK RKELEEKLVT LVQEKNDLQL QVQAESENLL
901 DAEERCDQLI KAKFQLEAKI KEVTERAEDE EEINAELTAK KRKLEDECSE LKKDIDDLEL
961 TLAKVEKEKH ATENKVKNLT EELSGLDETI AKLTREKKAL QEAHQQALDD LQAEEDKVNS
1021 LNKTKSKLEQ QVEDLESSLE QEKKLRVDLE RNKRKLEGDL KLAQESILDL ENDKQQLDER
1081 LKKKDFEYCQ LQSKVEDEQT LGLQFQKKIK ELQARIEELE EEIEAERATR AKTEKQRSDY
1141 ARELEELSER LEEAGGVTST QIELNKKREA EFLKLRRDLE EATLQHEAMV AALRKKHADS
1201 VAELGEQIDN LQRVKQKLEK EKSEFKLEID DLSSSMESVS KSKANLEKIC RTLEDQLSEA
1261 RGKNEEIQRS LSELTTQKSR LQTEAGELSR QLEEKESIVS QLSRSKQAFT QQTEELKRQL
1321 EEENKAKNAL AHALQSSRHD CDLLREQYEE EQEGKAELQR ALSKANSEVA QWRTKYETDA
1381 IQRTEELEEA KKKLAQRLQD SEEQVEAVNA KCASLEKTKQ RLQGEVEDLM VDVERANSLA
1441 AALDKKQRNF DKVLAEWKTK CEESQAELEA SLKESRSLST ELFKLKNAYE EALDQLETVK
1501 RENKNLEQEI ADLTEQIAEN GKTIHELEKS RKQIELEKAD IQLALEEAEA ALEHEEAKIL
1561 RIQLELTQVK SEIDRKIAEK DEEIEQLKRN YQRTVETMQS ALDAEVRSRN EAIRLKKKME
1621 GDLNEIEIQL SHANRQAAET LKHLRSVQGQ LKDTQLHLDD ALRGQEDLKE QLAIVERRAN
1681 LLQAEVEELR ATLEQTERAR KLAEQELLDS NERVQLLHTQ NTSLIHTKKK LETDLMQLQS
1741 EVEDASRDAR NAEEKAKKAI TDAAMMAEEL KKEQDTSAHL ERMKKNLEQT VKDLQHRLDE
1801 AEQLALKGGK KQIQKLETRI RELEFELEGE QKKNTESVKG LRKYERRVKE LTYQSEEDRK
1861 NVLRLQDLVD KLQVKVKSYK RQAEEADEQA NAHLTKFRKA QHELEEAEER ADIAESQVNK
1921 LRAKTRDFTS SRMVVHESEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYH3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- prostate: 27 nTPM
- skeletal muscle: 20 nTPM
- seminal vesicle: 17 nTPM
- esophagus: 8.6 nTPM
- colon: 8.1 nTPM
- tongue: 5.7 nTPM
Single-cell type
- early spermatids: 427 nCPM
- late primary spermatocytes: 297 nCPM
- thymic myoid cells: 132 nCPM
- myonuclei: 50 nCPM
- late spermatids: 46 nCPM
- hepatic stellate cells: 19 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- midbrain: 1.9 nTPM
- thalamus: 1.9 nTPM
- amygdala: 1.8 nTPM
- medulla oblongata: 1.8 nTPM
- white matter: 1.8 nTPM
- basal ganglia: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYH3.
Disease | AllUniProt
Conditions MYH3 is implicated in, by any mechanism.
- Arthrogryposis, distal, 2A (DA2A) MIM:193700
- Arthrogryposis, distal, 2B3 (DA2B3) MIM:618436
- Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A (CPSFS1A) MIM:178110
- Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B (CPSFS1B) MIM:618469
Disease | GeneticClinVar
127 pathogenic / likely-pathogenic of 1,925 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A
- MYH3-related disorder
- Contractures, pterygia, and variable skeletal fusions syndrome 1B
- Freeman-Sheldon syndrome
- Arthrogryposis, distal, type 2B3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.74
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament-based movement
- ATP metabolic process
- embryonic limb morphogenesis
- face morphogenesis
- muscle contraction
- muscle filament sliding
- muscle organ development
- sarcomere organization
- skeletal muscle contraction
Molecular functions
- actin filament binding
- ATP binding
- ATP hydrolysis activity
- calmodulin binding
- microfilament motor activity
- myosin phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myosin head, motor domain-like
- Myosin tail
- Myosin, SH3 domain
- Myosin S1 fragment, N-terminal
- DNA repair protein XRCC4-like, C-terminal
- P-loop containing nucleoside triphosphate hydrolase
- Kinesin motor domain superfamily
- Myosin head (motor domain)
- Myosin tail
- Myosin N-terminal SH3-like domain
- Class II myosin, Myh3, motor domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYH3 as an antibody target. Whether an autoantibody or antibody against MYH3 could matter depends on whether native MYH3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYH3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYH3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...